Skip to main content
. Author manuscript; available in PMC: 2016 Oct 31.
Published in final edited form as: Clin Infect Dis. 2015 Aug 30;62(1):90–98. doi: 10.1093/cid/civ708

Figure 1.

Figure 1

Adjusteda prevalence of (A) being prescribed antiretroviral therapy (ART) and (B) having human immunodeficiency virus (HIV) viral load <200 copies/mL, by private, Medicaid, or Medicare healthcare coverage and receipt of Ryan White HIV/AIDS Program (RWHAP) assistance among HIV-infected adults receiving medical care: Medical Monitoring Project, 2009–2013. Prevalence estimates are predicted probabilities from logistic regression model adjusted for (a) age, race, time since HIV diagnosis, and HIV disease stage and (b) age, race, nativity, poverty, education level, homelessness, and HIV disease stage. *P ≤ .01 for χ2 test comparing healthcare coverage with and without RWHAP.